Compare IRON & SLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | SLAB |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | N/A | 2000 |
| Metric | IRON | SLAB |
|---|---|---|
| Price | $94.29 | $138.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | $108.83 | ★ $144.90 |
| AVG Volume (30 Days) | ★ 533.0K | 265.1K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $742,807,000.00 |
| Revenue This Year | N/A | $36.85 |
| Revenue Next Year | N/A | $17.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.10 |
| 52 Week Low | $30.82 | $82.82 |
| 52 Week High | $97.12 | $160.00 |
| Indicator | IRON | SLAB |
|---|---|---|
| Relative Strength Index (RSI) | 62.96 | 63.28 |
| Support Level | $87.18 | $125.06 |
| Resistance Level | $96.18 | $128.07 |
| Average True Range (ATR) | 3.94 | 4.18 |
| MACD | -0.32 | 2.43 |
| Stochastic Oscillator | 56.25 | 82.00 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.